Fifth Third Bancorp’s Sanara MedTech SMTI Stock Holding History

Fifth Third Bancorp’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-27,037	Closed	-$898K	–	2605
2024 Q4	$898K	Buy	+27,037	New	+$917K	﹤0.01%	600

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Fifth Third Bancorp's SMTI Position: Q1 2025 in Review

Fifth Third Bancorp sold out of Sanara MedTech (SMTI) in Q1 2025, closing a stake of 27,037 shares — an estimated $898K sold.

Fifth Third Bancorp first reported a position in SMTI in Q4 2024 and held it in 1 quarter. The position peaked at $898K in Q4 2024. 49 funds tracked by Wall St. Rank hold SMTI as of Q1 2025.

Fifth Third Bancorp reported no remaining Sanara MedTech position as of Q1 2025 after selling out during the quarter.
Fifth Third Bancorp sold 27,037 Sanara MedTech shares in Q1 2025, an estimated $898K.
Fifth Third Bancorp first reported a position in Sanara MedTech in Q4 2024 and held it in 1 quarter.
Fifth Third Bancorp's Sanara MedTech position peaked at $898K in Q4 2024.
49 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2025.

Based on Fifth Third Bancorp's 13F filing for Q1 2025, filed 15 Apr 2025.